{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:04:20Z","timestamp":1790802260494,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010710","name":"Savitribai Phule Pune University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biochi.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:49:21Z","timestamp":1789602561000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The MAPK signalling landscape of Leishmania: structural diversity, biological functions and therapeutic potential"],"prefix":"10.1016","author":[{"given":"Priyanka","family":"Mazire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Chandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-5588","authenticated-orcid":false,"given":"Amit","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2026.09.009_bib1","unstructured":"World Health Organisation-Tropical Disease Research Program. Accessed on 25 February 2026."},{"key":"10.1016\/j.biochi.2026.09.009_bib2","series-title":"World Health Organisation","year":"2023"},{"key":"10.1016\/j.biochi.2026.09.009_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2024.102863","article-title":"A review on potential therapeutic targets for the treatment of leishmaniasis","volume":"100","author":"Sheikh","year":"2024","journal-title":"Parasitol. Int."},{"issue":"10","key":"10.1016\/j.biochi.2026.09.009_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012597","article-title":"The development of L. major, L. donovani and L. martiniquensis, Leishmania currently emerging in Europe, in the sand fly species Phlebotomus perniciosus and P. tobbi","volume":"18","author":"Sadlova","year":"2024","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.biochi.2026.09.009_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174436","article-title":"Advancement in leishmaniasis diagnosis and therapeutics: an update","volume":"910","author":"Kumari","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.biochi.2026.09.009_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/13543784.2024.2400139","article-title":"Investigational new drugs for the treatment of leishmaniasis","volume":"33","author":"Sundar","year":"2024","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.biochi.2026.09.009_bib7","article-title":"eBioMedicine. Leishmania: an urgent need for new treatments","volume":"87","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biochi.2026.09.009_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.37349\/eds.2024.00059","article-title":"A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules","volume":"2","author":"Masne","year":"2024","journal-title":"Explor Drug Sci"},{"issue":"5","key":"10.1016\/j.biochi.2026.09.009_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00028-4","article-title":"Bangladesh eliminates visceral leishmaniasis","volume":"5","author":"Nagi","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.biochi.2026.09.009_bib10","series-title":"Ending the Neglect to Attain the Sustainable Development Goals: a Road Map for Neglected Tropical Diseases 2021-2030","year":"2021"},{"key":"10.1016\/j.biochi.2026.09.009_bib11","series-title":"South-East Asia Regional Office. Regional Strategic Framework for Accelerating and Sustaining Elimination of Kala-azar in South-East Asia 2022\u20132026","year":"2022"},{"key":"10.1016\/j.biochi.2026.09.009_bib12","article-title":"Strategic framework for the elimination of visceral leishmaniasis in Eastern Africa 2023-2030","year":"2023","journal-title":"Brazzaville: WHO AFRO"},{"issue":"2","key":"10.1016\/j.biochi.2026.09.009_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ddr.21907","article-title":"Road-map of pre-clinical treatment for Visceral Leishmaniasis","volume":"83","author":"Mazire","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biochi.2026.09.009_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122844","article-title":"Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases","volume":"351","author":"Bhattacharjee","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.biochi.2026.09.009_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biochi.2021.10.012","article-title":"Pathogenic role of mitogen activated protein kinases in protozoan parasites","volume":"193","author":"Kaur","year":"2022","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.biochi.2026.09.009_bib16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/microorganisms9040691","article-title":"Leishmania protein kinases: important regulators of the parasite life cycle and molecular targets for treating leishmaniasis","volume":"9","author":"Efstathiou","year":"2021","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.biochi.2026.09.009_bib17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijpara.2007.04.008","article-title":"Leishmania MAP kinases-familiar proteins in an unusual context","volume":"37","author":"Wiese","year":"2007","journal-title":"Int. J. Parasitol."},{"issue":"4","key":"10.1016\/j.biochi.2026.09.009_bib18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/pathogens15040384","article-title":"Mitogen-Activated protein kinases: therapeutic signaling catalysts in viral immune evasion","volume":"15","author":"Khan","year":"2026","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.biochi.2026.09.009_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156627","article-title":"Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interface","volume":"179","author":"Bodhale","year":"2024","journal-title":"Cytokine"},{"issue":"5600","key":"10.1016\/j.biochi.2026.09.009_bib21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biochi.2026.09.009_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00894-009-0565-3","article-title":"Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors","volume":"16","author":"Awale","year":"2010","journal-title":"J. Mol. Model."},{"issue":"3","key":"10.1016\/j.biochi.2026.09.009_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050017","article-title":"Structural and functional diversity of the microbial kinome","volume":"5","author":"Kannan","year":"2007","journal-title":"PLoS Biol."},{"issue":"6","key":"10.1016\/j.biochi.2026.09.009_bib24","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190072","article-title":"Regulation of gene expression in trypanosomatids: living with polycistronic transcription","volume":"9","author":"Clayton","year":"2019","journal-title":"Open Biol."},{"key":"10.1016\/j.biochi.2026.09.009_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-6-127","article-title":"Comparative analysis of the kinomes of three pathogenic trypanosomatids: leishmania major, Trypanosoma brucei and Trypanosoma cruzi","volume":"6","author":"Parsons","year":"2005","journal-title":"BMC Genom."},{"issue":"10","key":"10.1016\/j.biochi.2026.09.009_bib26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.str.2012.07.005","article-title":"The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms","volume":"20","author":"Horjales","year":"2012","journal-title":"Structure"},{"issue":"11","key":"10.1016\/j.biochi.2026.09.009_bib27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ijpara.2007.03.006","article-title":"Over-expression of Leishmania major MAP kinases reveals stage-specific induction of phosphotransferase activity","volume":"37","author":"Morales","year":"2007","journal-title":"Int. J. Parasitol."},{"issue":"14","key":"10.1016\/j.biochi.2026.09.009_bib28","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0020-7519(03)00252-2","article-title":"Identification of mitogen-activated protein kinase homologues from Leishmania mexicana","volume":"33","author":"Wiese","year":"2003","journal-title":"Int. J. Parasitol."},{"issue":"5","key":"10.1016\/j.biochi.2026.09.009_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.molcel.2004.08.024","article-title":"Regulation of protein kinases; controlling activity through activation segment conformation","volume":"15","author":"Nolen","year":"2004","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.biochi.2026.09.009_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004347","article-title":"Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability","volume":"10","author":"Cayla","year":"2014","journal-title":"PLoS Pathog."},{"issue":"7873","key":"10.1016\/j.biochi.2026.09.009_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biochi.2026.09.009_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14789450.2025.2456046","article-title":"AlphaFold and what is next: bridging functional, systems and structural biology","volume":"22","author":"Szczepski","year":"2025","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.biochi.2026.09.009_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.906437","article-title":"AlphaFold 2 and NMR spectroscopy: partners to understand protein structure, dynamics and function","volume":"9","author":"Laurents","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biochi.2026.09.009_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.apha.2025.01.007","article-title":"Molecular dynamics simulations: insights into protein and protein ligand interactions","volume":"103","author":"Grewal","year":"2025","journal-title":"Adv. Pharmacol."},{"issue":"8","key":"10.1016\/j.biochi.2026.09.009_bib35","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41589-024-01679-1","article-title":"Machine learning in preclinical drug discovery","volume":"20","author":"Catacutan","year":"2024","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib36","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1038\/s41467-024-52061-7","article-title":"An artificial intelligence accelerated virtual screening platform for drug discovery","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.biochi.2026.09.009_bib37","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1074\/jbc.REV118.005602","article-title":"Challenges and opportunities in cryo-EM single-particle analysis","volume":"294","author":"Lyumkis","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.biochi.2026.09.009_bib38","doi-asserted-by":"crossref","first-page":"17783","DOI":"10.1073\/pnas.0607656103","article-title":"Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism","volume":"103","author":"Kornev","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2026.09.009_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/971968","article-title":"Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens","volume":"2011","author":"Brumlik","year":"2011","journal-title":"J Signal Transduct"},{"issue":"6","key":"10.1016\/j.biochi.2026.09.009_bib40","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1365-2958.2012.08169.x","article-title":"Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase","volume":"85","author":"Mandal","year":"2012","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11686-021-00463-8","article-title":"Mitogen-Activated protein kinase and aquaglyceroporin gene expression in treatment failure Leishmania major","volume":"67","author":"Somee","year":"2022","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.biochi.2026.09.009_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112100","article-title":"Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection","volume":"134","author":"Kumari","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/EC.00196-09","article-title":"Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage","volume":"9","author":"Morales","year":"2010","journal-title":"Eukaryot. Cell"},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molbiopara.2005.03.007","article-title":"An essential, putative MEK kinase of Leishmania major","volume":"142","author":"Agron","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.00736-11","article-title":"Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance","volume":"56","author":"Ashutosh","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.biochi.2026.09.009_bib46","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/AAC.04816-14","article-title":"MAPK1 of Leishmania donovani modulates antimony susceptibility by downregulating P-glycoprotein efflux pumps","volume":"59","author":"Garg","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biochi.2026.09.009_bib47","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00436-012-2823-z","article-title":"Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani","volume":"111","author":"Kumar","year":"2012","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52774-6","article-title":"Biochemical characterization and chemical validation of Leishmania MAP Kinase-3 as a potential drug target","volume":"9","author":"Raj","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09725-w","article-title":"MAPK1 of Leishmania donovani interacts and phosphorylates HSP70 and HSP90 subunits of foldosome complex","volume":"7","author":"Kaur","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2026.09.009_bib51","article-title":"Comparative phosphoproteomic analysis unravels MAPK1 regulated phosphoproteins in Leishmania donovani","volume":"240","author":"Kaur","year":"2021","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.biochi.2026.09.009_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110496","article-title":"An integrative in silico and in vitro study identifies Leishmania donovani MAP kinase12 as a probable virulence factor","volume":"121","author":"Mazire","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biochi.2026.09.009_bib53","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/emboj\/17.9.2619","article-title":"A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host","volume":"17","author":"Wiese","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.biochi.2026.09.009_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-9292-4-6","article-title":"LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes of Leishmania mexicana","volume":"4","author":"Wang","year":"2005","journal-title":"Kinetoplastid Biol. Dis."},{"issue":"4","key":"10.1016\/j.biochi.2026.09.009_bib55","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/EC.2.4.769-777.2003","article-title":"Protein kinase involved in flagellar-length control","volume":"2","author":"Wiese","year":"2003","journal-title":"Eukaryot. Cell"},{"issue":"4","key":"10.1016\/j.biochi.2026.09.009_bib56","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1091\/mbc.e05-10-0976","article-title":"Interacting protein kinases involved in the regulation of flagellar length","volume":"17","author":"Erdmann","year":"2006","journal-title":"Mol. Biol. Cell"},{"issue":"5","key":"10.1016\/j.biochi.2026.09.009_bib57","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/j.1365-2958.2005.04498.x","article-title":"LmxMPK9, a mitogen-activated protein kinase homologue affects flagellar length in Leishmania mexicana","volume":"55","author":"Bengs","year":"2005","journal-title":"Mol. Microbiol."},{"issue":"3","key":"10.1016\/j.biochi.2026.09.009_bib58","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00253-014-6168-7","article-title":"Linear B-cell epitope mapping of MAPK3 and MAPK4 from Leishmania braziliensis: implications for the serodiagnosis of human and canine leishmaniasis","volume":"99","author":"Menezes-Souza","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.biochi.2026.09.009_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s004300100072","article-title":"Homologues of LMPK, a mitogen-activated protein kinase from Leishmania mexicana, in different Leishmania species","volume":"190","author":"Wiese","year":"2001","journal-title":"Med. Microbiol. Immunol."},{"issue":"12","key":"10.1016\/j.biochi.2026.09.009_bib60","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1016\/j.ejmech.2010.09.020","article-title":"Mitogen-activated protein kinase 4 of Leishmania parasite as a therapeutic target","volume":"45","author":"Saravanan","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.biochi.2026.09.009_bib61","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ijpara.2010.02.004","article-title":"LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5","volume":"40","author":"John von Freyend","year":"2010","journal-title":"Int. J. Parasitol."},{"issue":"5","key":"10.1016\/j.biochi.2026.09.009_bib62","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1365-2958.2005.04614.x","article-title":"LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation","volume":"56","author":"Kuhn","year":"2005","journal-title":"Mol. Microbiol."},{"issue":"9","key":"10.1016\/j.biochi.2026.09.009_bib63","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/IAI.70.9.5026-5035.2002","article-title":"Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages","volume":"70","author":"Junghae","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biochi.2026.09.009_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105568","article-title":"Interferon inducible guanylate binding protein 1 restricts the growth of Leishmania donovani by modulating the level of cytokines\/chemokines and MAP kinases","volume":"168","author":"Kumar","year":"2022","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.biochi.2026.09.009_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"11","key":"10.1016\/j.biochi.2026.09.009_bib66","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012735","article-title":"Progress in antileishmanial drugs: mechanisms, challenges, and prospects","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"8","key":"10.1016\/j.biochi.2026.09.009_bib68","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/AAC.48.8.3033-3042.2004","article-title":"Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity","volume":"48","author":"Grant","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biochi.2026.09.009_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12539-013-0164-y","article-title":"Homology modeling of LmxMPK4 of Leishmania mexicana and virtual screening of potent inhibitors against it","volume":"5","author":"Gupta","year":"2013","journal-title":"Interdiscip Sci"},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12539-015-0269-6","article-title":"In Silico elucidation and inhibition studies of selected phytoligands against mitogen-activated protein kinases of protozoan parasites","volume":"8","author":"Gupta","year":"2016","journal-title":"Interdiscip Sci"},{"issue":"4","key":"10.1016\/j.biochi.2026.09.009_bib71","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.bbrc.2017.09.135","article-title":"The p38 MAP kinase inhibitor, PD 169316, inhibits flagellar motility in Leishmania donovani","volume":"493","author":"Reddy","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.biochi.2026.09.009_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221331","article-title":"Identification of lead molecules against potential drug target protein MAPK4 from L. donovani: an in-silico approach using docking, molecular dynamics and binding free energy calculation","volume":"14","author":"Raj","year":"2019","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.biochi.2026.09.009_bib73","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.3390\/molecules25143178","article-title":"Alkyl and Aryl derivatives based on p-Coumaric acid modification and inhibitory action against Leishmania braziliensis and Plasmodium falciparum","volume":"25","author":"Lopes","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biochi.2026.09.009_bib74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijbiomac.2022.02.047","article-title":"Biofunctionalized Chrysin-conjugated gold nanoparticles neutralize Leishmania parasites with high efficacy","volume":"205","author":"Raj","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.biochi.2026.09.009_bib75","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s11030-020-10139-6","article-title":"Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-\/structure-based virtual screening approach","volume":"25","author":"Herrera-Acevedo","year":"2021","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.009_bib76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11686-023-00659-0","article-title":"In Vitro and In Silico studies of kinase inhibitor of MAPK3 protein to determine Leishmania martiniquensis treatment","volume":"68","author":"Aiebchun","year":"2023","journal-title":"Acta Parasitol."},{"issue":"3","key":"10.1016\/j.biochi.2026.09.009_bib77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/JVBD.JVBD_174_23","article-title":"Molecular docking of daunorubicin and etoposide drugs against Leishmania donovani: a theoretical study","volume":"61","author":"Shakoori","year":"2024","journal-title":"J. Vector Borne Dis."},{"issue":"5","key":"10.1016\/j.biochi.2026.09.009_bib78","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.25044","article-title":"Identification of MAPK3 inhibitors against Leishmania spp. via in silico and in vitro approaches","volume":"26","author":"Kumsiri","year":"2025","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.biochi.2026.09.009_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118276","article-title":"Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines","volume":"128","author":"Shahid","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.biochi.2026.09.009_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12687","article-title":"LmjMAPK10 offers protection against Leishmania donovani infection","volume":"42","author":"Kumar","year":"2020","journal-title":"Parasite Immunol."},{"issue":"48","key":"10.1016\/j.biochi.2026.09.009_bib81","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1016\/j.vaccine.2011.04.030","article-title":"Leishmania major MAP kinase 10 is protective against experimental L. major infection","volume":"29","author":"Kumari","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2026.09.009_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156475","article-title":"Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani","volume":"174","author":"Kumar","year":"2024","journal-title":"Cytokine"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426002282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426002282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:23:57Z","timestamp":1790799837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908426002282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":82,"alternative-id":["S0300908426002282"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.09.009","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The MAPK signalling landscape of Leishmania: structural diversity, biological functions and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}